๊ธฐ๋ณธ ์ •๋ณด
  • ์ œํ’ˆ๋ช… ::
  • ๋ถ„๋ฅ˜ :: ์ฝœ๋ฆฐ์„ฑ ์ž‘์šฉ์ œ > ๊ฐ„์ ‘ ์ž‘์šฉ์„ฑ (Acetylcholinesterase inhibitor)
  • ํŠน์ง• ::
  • ์ž„์ƒ ::
๊ด€๋ จ ๋ฌธ์„œ
  • ์•ฝ๋ฆฌ1(A) - Ch.4-5 ์ฝœ๋ฆฐ์„ฑ ์ž‘์šฉ์ œ์™€ ๊ธธํ•ญ์ œ
    • ๊ฐ„์ ‘ ์ž‘์šฉ์„ฑ ์ฝœ๋ฆฐ์„ฑ ์ž‘์šฉ์ œ๋Š” ์•„์„ธํ‹ธ์ฝœ๋ฆฐ์„ ๋ถ„ํ•ดํ•˜๋Š” ํšจ์†Œ AChE(Acetylcholinesterase)๋ฅผ ์–ต์ œํ•จ์œผ๋กœ์จ ์ฝœ๋ฆฐ์„ฑ ๋‰ด๋Ÿฐ์„ ์ด‰์ง„์‹œํ‚ค๋Š” ์ž‘์šฉ์„ ๋‚˜ํƒ€๋‚ธ๋‹ค. ๊ฐ€์—ญ์  ํ•ญ์ฝœ๋ฆฐ์—์Šคํ„ฐ๋ผ์•„์ œ์™€ ๋น„๊ฐ€์—ญ์  ํ•ญ์ฝœ๋ฆฐ์—์Šคํ„ฐ๋ผ์•„์ œ๊ฐ€ ์žˆ๋‹ค.
    • ๊ฐ€์—ญ์  ํ•ญ์ฝœ๋ฆฐ์—์Šคํ„ฐ๋ผ์•„์ œ(anticholinesterases)๋Š” AChE์˜ ์–ต์ œ์ œ๋กœ์„œ ACh์˜ ๋ถ„ํ•ด๋ฅผ ๋ง‰์•„ ACh๋ฅผ ์ถ•์ ์‹œํ‚จ๋ฉฐ, ๋ชจ๋“  ์ฝœ๋ฆฐ์„ฑ ์ˆ˜์šฉ์ฒด์˜ ๋ฐ˜์‘์„ ์ผ์œผํ‚จ๋‹ค. Edrophonium(์—๋“œ๋กœํฌ๋Š„), physostigmine(ํ”ผ์ฃ ์Šคํ‹ฐ๊ทธ๋ฏผ), neostigmine(๋„ค์˜ค์Šคํ‹ฐ๊ทธ๋ฏผ) ๋“ฑ์ด ์žˆ๋‹ค.
๊ด€๋ จ ์ˆ˜์—… ๋‚ด์šฉ

Diagnosis

  • P/E (๊ตฌํ† ๋ณด๋‹ค ํ† ์ถœ)
  • X-ray (ํ์ƒ‰ ์—†์ด ์‹๋„ํ™•์žฅ๋งŒ ์žˆ๋Š” ๊ฑด์ง€ ํ™•์ธ)
  • Fluoroscopy (gastroesophageal reflux ํ™•์ธ)
  • ์•„๋ž˜ ํ•ญ๋ชฉ๋“ค๋กœ ๊ฒ€์‚ฌ ๊ฐ€๋Šฅ, ๋‹ค ๋ฐฐ์ œ๋˜๋ฉด idiopathic
์ง„๋‹จ ๊ฒ€์‚ฌR/O
Acetylcholine receptor antibodies titration
(MG : AchE receptor์— ํ•ญ์ฒด๊ฐ€ ๋ถ™์–ด ์•„์„ธํ‹ธ์ฝœ๋ฆฐ ๋ฐ˜์‘ ์ €ํ•˜)
โ‡’ ๋ฉด์—ญ๋งค๊ฐœ์„ฑ myasthenia gravis
* Tensilon test : ์œ„์Œ์„ฑ ๊ฐ€๋Šฅ์„ฑ ๋˜๋Š” ๋น„์šฉ ๋ถ€๋‹ด์œผ๋กœ ์ธํ•ด ์น˜๋ฃŒ ๋ชฉ์ ์˜ ์ง„๋‹จ์„ ํ•˜๊ณ  ์‹ถ๋‹ค๋ฉด.<
Resting serum cortisolโ‡’ Occult hypoadrenocorticism
Electromyographyโ‡’ Generalized neuropathies / myopathies
Dysautonomia (์ž์œจ์‹ ๊ฒฝ๊ณ„ ์ด์ƒ์ฆ ๊ฒ€์‚ฌ)โ‡’ Dysautonomia
Thyroid panel
๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅ์ €ํ•˜์ฆ์ด๋ฉด โ†’ negative feedback์œผ๋กœ TSH ๊ณ„์† ๋ถ„๋น„.
โœ”๏ธ Thyroxine ๋‚ฎ๊ณ  (serum thyroxine, free thyroxine โ†“)
โœ”๏ธ TSH (thyroid-stimulating hormone) ๋†’์œผ๋ฉด ๊ฐ‘๊ธฐ์ € ํ™•์ง„.
โ‡’ Hypothyroidism (dogs)

Tensilon test (edrophonium test)

  • Edrophonium์€ 5-10๋ถ„ ์ •๋„ ์งง๊ฒŒ ์œ ์ง€๋˜๋Š” ์ฃผ์‚ฌ์ œ.
  • ๊ณผ๋„ํ•œ ์šด๋™์œผ๋กœ ํƒˆ๋ ฅ ์ƒํƒœ๋ฅผ ์œ ๋ฐœํ•œ ๋’ค, ์•ฝ๋ฌผ์„ ์จ์„œ ๊ทธ ์ฆ์ƒ์ด ์‚ฌ๋ผ์ง€๋ฉด MG๋กœ ์ง„๋‹จ.
  • ํ˜น์€ Focal MG์˜€์„ ๊ฒฝ์šฐ ์ผ์‹œ์ ์œผ๋กœ ๊ฑฐ๋Œ€์‹๋„์ฆ์ด ์™„ํ™”๋จ.
  • ๊ต๊ฐ์‹ ๊ฒฝ & ๋ถ€๊ต๊ฐ ์‹ ๊ฒฝ์— ๋ชจ๋‘ ์ด์ƒ์ด ๋ฐœ์ƒ but ์ฃผ๋กœ ๋ถ€๊ต๊ฐ ์‹ ๊ฒฝ์— ๋ฌธ์ œ
  • dilated colon, dry nose, dilated pupils, keratoconjunctivitis sicca, bradycardia
    • ์ฆ์ƒ๋„ ์ฃผ๋กœ ๋ถ€๊ต๊ฐ ์‹ ๊ฒฝ (์ถ•๋™, ์žฅ๊ธฐ ์—ฐ์ถ• ์šด๋™, ์„œ๋งฅ ์œ ๋ฐœ, ๋ˆˆ๋ฌผ) ๊ด€๋ จ
      : ์‚ฐ๋™, ์žฅ๊ธฐ ๋Š˜์–ด๋‚จ, ๊ฑด์„ฑ ๊ฐ๊ฒฐ๋ง‰์—ผ ๋“ฑ
    • ๋‹จ ๊ต๊ฐ ์‹ ๊ฒฝ๋„ ๊ฐ™์ด ์ €ํ•˜๋˜๋ฉด์„œ ๋นˆ๋งฅ์ด ์•„๋‹Œ ์„œ๋งฅ์ด ์ฐพ์•„์˜ด.
Link to original

Treatment

  • Localized myasthenia (Focal MG ์น˜๋ฃŒ)

    • Anticholinesterase (edrophonium, pyridostigmine, neostigmine)
      • Pyridostigmine์€ ๊ฒฝ๊ตฌ์ œ๋กœ ๊ฐ€๋Šฅํ•˜๊ณ  8์‹œ๊ฐ„ ์ •๋„ ์ง€์†. ์น˜๋ฃŒ ๋ชฉ์ ์œผ๋กœ ์ž˜ ์‚ฌ์šฉ.
      • ๋ถ€์กฑํ•œ acetylcholine์„ ์ฑ„์›Œ์ฃผ๊ธฐ ์œ„ํ•ด ๊ณ„์† ๊ฒฝ๊ตฌ์ œ๋กœ ๋ณต์šฉ
    • ๋ฉด์—ญ์–ต์ œ์ œ ์น˜๋ฃŒ (azathioprine, prednisolone) : ๊ทผ๋ณธ์ ์ธ ๋ฌธ์ œ ํ•ด๊ฒฐ ์‹œ๋„
  • Gastroesophageal reflux (์—ญ๋ฅ˜๋กœ ์ธํ•œ ์‹๋„ ์†์ƒ ๋ฐฉ์ง€)

    • Prokinetic (cisapride 0.25mg/kg) : ์‹๋„ ์šด๋™์„ฑ์„ ๋†’์—ฌ ์ •์ฒด๋˜์ง€ ์•Š๋„๋ก
    • Antacid (์ œ์‚ฐ์ œ, omeprazole 1-2mg/kg) : ๊ฐ•ํ•œ ์‚ฐ์„ฑ์„ ์ค‘ํ™”. ํ•ญํžˆ์Šคํƒ€๋ฏผ์ œ๋ณด๋‹ค PPi๊ฐ€ ํšจ๊ณผ ์ข‹์Œ.
  • Idiopathic โ†’ conservative dietary therapy (์‹๋‹จ ์กฐ์ ˆ์ด ์ œ์ผ. ์„œ์„œ ๋ฐฅ์„ ๋จน์ด๊ฑฐ๋‚˜ ์—ญ๋ฅ˜๋ฅผ ์ค„์ด๋Š”..)

  • Gastrostomy tubes : ์‹ฌํ•  ๋•Œ ์ ์šฉํ•  ์ˆ˜ ์žˆ์ง€๋งŒ, ํ•˜์ง€๋งŒ ๋งˆ์ทจ์— ์˜ํ•œ reflux ์ฆ๊ฐ€ ๋•Œ๋ฌธ์— ์œ„ํ—˜

Link to original


Neuromuscular junction disorder

  • ์‹ ๊ฒฝ์ „๋‹ฌ๋ฌผ์งˆ (acetylcholine ๋“ฑ) : nerve ending์—์„œ muscle๋กœ ์‹ ํ˜ธ ์ „๋‹ฌ, ์ ์œผ๋ฉด ๋ชธ์— ํž˜์ด ์—†์ด ๋Š˜์–ด์ง€๊ณ , ๋งŽ์œผ๋ฉด ๊ทผ์œก ๊ฐ•์ง ๋“ฑ
  • ์ค‘์ฆ๊ทผ๋ฌด๋ ฅ์ฆ โ†’ ๋›ฐ์–ด๋‹ค๋‹ˆ๋‹ค๊ฐ€ ๊ฐ‘์ž๊ธฐ ์“ฐ๋Ÿฌ์ง
    • ์„ ์ฒœ์„ฑ ์ค‘์ฆ ๊ทผ๋ฌด๋ ฅ์ฆ : acetylcholine ์ˆ˜์šฉ์ฒด๊ฐ€ ๋ถ€์กฑํ•˜๊ฒŒ ํƒœ์–ด๋‚จ.
    • Acquired myasthenia gravis (ํ›„์ฒœ์„ฑ ์ค‘์ฆ ๊ทผ๋ฌด๋ ฅ์ฆ) : acetylcholine receptor์— ๋Œ€ํ•œ antibody๊ฐ€ ํ˜•์„ฑ๋˜์–ด ๋Œ€์‹  ๋ถ™์Œ. โ†’ ๋งˆ๋น„
      • ์ง„๋‹จํ•˜๋ ค๋ฉด Ach receptor Ab๋ฅผ ๊ฒ€์‚ฌํ•˜๋ฉด ๋จ.
  • Acetylcholinesterase inhibitor (edrophonium, neostigmine, pyridostigmine) โ†’ Ach ๋ถ„ํ•ด๋ฅผ ์–ต์ œ, ์ค‘์ฆ๊ทผ๋ฌด๋ ฅ์ฆ ์น˜๋ฃŒ
    • ๋ถ€์ž‘์šฉ : ์†Œํ™”๊ธฐ๊ณ„์˜ ๊ณผ๋„ํ•œ ์šด๋™์œผ๋กœ ์„ค์‚ฌ๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ์Œ
  • Tensilon (edrophonium) test ๋ฅผ ํ†ตํ•ด ์ค‘์ฆ๊ทผ๋ฌด๋ ฅ์ฆ์„ ํ…Œ์ŠคํŠธํ•จ. (์น˜๋ฃŒ์  ์ง„๋‹จ)
  • ๊ตญ์†Œ์  ๋˜๋Š” ์ „์‹ ์ ์œผ๋กœ ์˜ค๋Š” motility disorder.

Megaesophagus๋ฅผ ์œ ๋ฐœํ•˜๋Š” ์›์ธ

  • Myasthenia gravis
  • Esophagitis
  • Endocrine disease (๋‚ด๋ถ„๋น„ ์งˆํ™˜)
    • hypothyroidism, Addisonโ€™s disease
  • SLE, polymyopathies (๋‹ค๋ฐœ์„ฑ ๊ทผ์—ผ)
  • Idiopathic
  • Thymoma (thymus์— ์ƒ๊ธด cancer)
  • Botulism (์Œ์‹ ์ž˜๋ชป ๋จน์–ด์„œ ๋…์†Œ ๋ฐœ์ƒ)

Further examination

  • Ach receptor antibody test
  • ANA test : SLE ๊ฐ๋ณ„
  • Thyroid profile (T4, fT4, TSH, Thyroid Ab)
  • ACTH stimulation test : Cushing, Addison ๊ฐ๋ณ„

๐Ÿ“‹ Case 2 : Acquired MG

Case) 12yrs, YT, 2.7kg, Regurgitation
๊ฒฝ๋ถ€ X-ray
- ๊ฒฝ๋ถ€ esophagus๊ฐ€ ํ™•์žฅ๋˜๊ณ , ๊ณต๊ธฐ๊ฐ€ ์ฐจ ์žˆ์Œ (๊ฒ€์€์ƒ‰)
- ์ด๋ฌผ์งˆ, ์ข…์–‘ ์˜์‹ฌ ์†Œ๊ฒฌ์€ ์•ˆ ๋ณด์ž„
- ์‹๋„์˜ motility์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธด ๊ฒƒ์œผ๋กœ ์˜์‹ฌ, ์กฐ์˜์ œ
(์ด์ œ๋Š” ๊ธฐ์ˆ ์ด ๋ฐœ์ „ํ•ด fluoroscopy ์ดฌ์˜ํ•˜๋ฉด ๋จ)
๋ฐ”๋ฅจ ์กฐ์˜์ œ X-ray
- 5๋ถ„ ๋‚ด๋กœ ์‹๋„์—์„œ ๋ฐ”๋ฅจ ์•ˆ ๋ณด์—ฌ์•ผ ์ •์ƒ.
- ์ด ํ™˜์ž๋Š” 30๋ถ„์ด ์ง€๋‚˜๋„ ์‹๋„์—์„œ ๋ฐ”๋ฅจ ๋ณด์ž„.
- ์œ„, ์žฅ์—์„œ๋Š” ์ž˜ ์ด๋™ํ•˜๊ณ  ์žˆ์Œ.
โ‡’ ์‹๋„์˜ ์šด๋™์„ฑ ์ €ํ•˜ (esophageal hypomotility)

- Neuromuscular dz๋Š” ๋ถ€์œ„๋ณ„๋กœ ๋‹ค๋ฅด๊ฒŒ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ.
- ์‹๋„ ๋ฌด๊ธด์žฅ์ฆ โ†’ ์—ฐ๋™์šด๋™ ๋ถˆ๊ฐ€๋กœ ์ธํ•œ ์—ญ๋ฅ˜
*๋ฌด๊ธด์žฅ์ฆ(atony) : ๊ทผ์œก์˜ ๊ธด์žฅ์ด ๊ฐํ‡ด ๋˜๋Š” ์†Œ์‹ค๋œ ์ƒํƒœ
*์œ„ atony โ†’ ์žฅ์œผ๋กœ ๋‚ด์šฉ๋ฌผ ์ด๋™ ๋ถˆ๊ฐ€

- ์‹๋„ ์ „์ฒด ๋งˆ๋น„๊ฐ€ ์•„๋‹Œ, ์ƒ๋ถ€ ์‹๋„ ๋ถ€๊ทผ์—๋งŒ ๋ถ€๋ถ„์ ์œผ๋กœ ๋งˆ๋น„๊ฐ€ ์˜จ ์ผ€์ด์Šค.

โ‡’ ์ค‘์ฆ ๊ทผ๋ฌด๋ ฅ์ฆ ์ดˆ๊ธฐ
Neostigmine ํˆฌ์—ฌ (tensilon test)
- Ach-esterase inhibitor ์‚ฌ์šฉ
โ†’ ์‹๋„ ๊ทผ์œก์˜ ์šด๋™์„ฑ์ด ํšŒ๋ณต๋˜์–ด ์กฐ์˜์ œ ๋‚ด๋ ค๊ฐ
- AchE inhibitor๋Š” ์†Œํ™”๊ธฐ๊ณ„์˜ ๊ณผ๋„ํ•œ ์šด๋™์œผ๋กœ ์„ค์‚ฌ ์œ ๋ฐœ ์นด๊ณต

- ์‹ ๊ฒฝ๊ทผ ๋ฌธ์ œ์˜ ๋Œ€ํ‘œ์ ์ธ ์ž„์ƒ์ฆ์ƒ์€ ๊ตฌํ† 
(๐Ÿ’Š ํ•ญ๊ตฌํ† ์ œ(antiemetics) : metronidazole, ondansetron, maropitant)
- ์ง„๋‹จ ์—†์ด ๊ตฌํ† ์— ๋Œ€ํ•œ ๋Œ€์ฆ์น˜๋ฃŒ๋งŒ?
โ†’ ์‹ฌ์žฅ๊ทผ ๋ฌธ์ œ๋กœ ์ง„ํ–‰๋˜์–ด ์‹ฌ์žฅ๋งˆ๋น„๋กœ ์‚ฌ๋งํ•  ์ˆ˜ ์žˆ์Œ.
- Ach receptor Ab ์–‘์„ฑ
โ‡’ Dx : Acquired focal Myasthenia gravis
๐Ÿ’Š pyridostigmine (1mg/kg BID PO) : AchE inhibitor
๐Ÿ’Š mosapride (1.5mg/kg BID PO) : Prokinetics

๐Ÿ“‹ Case 3 : Thymoma-induced MG

S

Schnauzer / 8Y / IM / CC : Vomiting, Regurgitation, Hypersalivation (1์ฃผ ์ „

O
  • X-ray ์ดฌ์˜

  • Fluoroscopy โ†’ ์‹๋„ ์šด๋™์„ฑ ๊ฐ์†Œ / ํ•˜๋ถ€ ์‹๋„ ๊ด„์•ฝ๊ทผ ๊ธด์žฅ๋„ ๊ฐ์†Œ / ์œ„์—์„œ ์—ญ๋ฅ˜(regurgitation)

  • Serum Ach receptor Ab ์–‘์„ฑ (2.93nmol/L)

A & P

โ‡’ Acquired myasthenia gravis (focal form)

Progress note

  • 1์ฐจ ์•ฝ๋ฌผ ์น˜๋ฃŒ | mosapride (1.5mg/kg BID), standing position after feeding
  • 1์ฃผ ๋’ค | ์ž„์ƒ ์ฆ์ƒ ๊ฐœ์„ (vomiting, regurgitation, hypersalivation), but ์•ฝ์„ ๋Š์œผ๋ฉด 8์‹œ๊ฐ„ ํ›„ ์žฌ๋ฐœ
  • 2์ฐจ ์•ฝ๋ฌผ ์น˜๋ฃŒ | ๊ณ„์† ์ฆ์ƒ ์žฌ๋ฐœ, ์น˜๋ฃŒ๊ฐ€ ์•ˆ ๋˜์–ด ์•ฝ ์šฉ๋Ÿ‰ ๋Š˜๋ฆผ โ‡’ mosapride (BID โ†’ TID)
  • ๋ถ€๋ถ„์ ์œผ๋กœ ๋ฐ˜์‘, ์‹๋„์—์„œ ์ž˜ ์•ˆ ๋‚ด๋ ค๊ฐ (Partial improvement - ์‹๋„ ์šด๋™์„ฑ ๊ฐ์†Œ, ํ•˜๋ถ€ ์‹๋„ ๊ด„์•ฝ๊ทผ ๊ธด์žฅ๋„ ๊ฐ์†Œ, mildํ•œ ์—ญ๋ฅ˜
  • 10์ฃผ ๋’ค | ์ž„์ƒ ์ฆ์ƒ ์•…ํ™” (intermittent hypersalivation) : MG ์น˜๋ฃŒ๋ฅผ 10์ฃผ ํ–ˆ๋Š”๋ฐ๋„ ํฌํ•œํ•˜๊ฒŒ ์•ˆ ๋‚˜์Œ.
  • 3์ฐจ ์•ฝ๋ฌผ ์น˜๋ฃŒ | ์•ฝ๋ฌผ ์šฉ๋Ÿ‰ ์˜ฌ๋ฆผ โ‡’ mosapride (1.5 โ†’ 2.5 mg/kg TID)
    • Barium ๋„ฃ์—ˆ์„ ๋•Œ ๋‹ค์‹œ ์ „์ฒ˜๋Ÿผ ์—„์ฒญ ์ฒœ์ฒœํžˆ ๋‚ด๋ ค๊ฐ
  • 12์ฃผ ๋’ค | ์•ฝ๋ฌผ ์šฉ๋Ÿ‰์ด ๋ถ€์กฑํ–ˆ๋‚˜..? ๊ทผ๋ฐ hypersalivation, ๋นˆ๋งฅ ๋“ฑ ๋ถ€์ž‘์šฉ๋งŒ ๋ฐœ์ƒ

(์ง€๊ธˆ๊นŒ์ง€ ๊ฒ€์‚ฌ์™€ ์น˜๋ฃŒ์—๋งŒ 1500๋งŒ์› ์ผ๋Š”๋ฐ ์ง„๋‹จ์ด ์•ˆ ๋จ..) โ†’ ์ž‘์€ thymoma๊ฐ€ ์žˆ์„ ์ˆ˜ ์žˆ์œผ๋‹ˆ ๊ฒ€์‚ฌ๋ฅผ ํ•œ๋ฒˆ ๋” ํ•ด๋ณด์ž.

CT ์ดฌ์˜
- artery๋Š” ์ž‘์ง€๋งŒ ์•ˆ์— ๋นˆ ๊ณต๊ฐ„์ด ์—†์ด ํ•˜์–—๋‹ค (ํ˜ˆ์•ก ํ๋ฆ„์ด ๋น ๋ฆ„)
- vein์€ ์ข€ ๋” ํฌ๊ณ  ๊ฐ€์šด๋ฐ๊ฐ€ ๋„๋„›์ฒ˜๋Ÿผ ๋น„์–ด ์žˆ๋‹ค (ํ˜ˆ์•ก ํ๋ฆ„์ด ๋А๋ฆผ)
- ๊ทธ๋Ÿฐ๋ฐ artery๋„ vein๋„ ์•„๋‹Œ ๋ฌด์–ธ๊ฐ€๊ฐ€ ์žˆ๋‹ค - ๋˜๊ฒŒ ์ž‘์•„์„œ X-ray์—์„œ๋„ ๋‚˜์˜ค์ง€ ์•Š์Œ.
โ‡’ CT์ƒ ์ž‘์€ thymoma๊ฐ€ ๊ด€์ฐฐ๋จ.
โ‡’ ์ˆ˜์ˆ ์ ์œผ๋กœ ์ œ๊ฑฐํ–ˆ๋”๋‹ˆ ์•ฝ๋„ ํ•„์š” ์—†์ด ์ฆ์ƒ์ด ์‹น ๋‚˜์Œ.

โ‡’ ์ตœ์ข… ์ง„๋‹จ : Thymoma์— ์˜ํ•œ ์ค‘์ฆ ๊ทผ๋ฌด๋ ฅ์ฆ (์šฐ๋ฆฌ๋‚˜๋ผ ์ตœ์ดˆ์˜ ์ผ€์ด์Šค) (๊ต๊ณผ์„œ์—์„œ๋Š” thymoma = cranial mediastinum์˜ ํฐ ์ข…์–‘์ด๋ผ๊ณ  ๋‚˜์˜ด, ํ•˜์ง€๋งŒ ์ด๋ ‡๊ฒŒ ์ž‘์€ small size thymoma๋„ ์žˆ์„ ์ˆ˜ ์žˆ๋‹ค. ๊ต๊ณผ์„œ์—๋Š” ์ „ํ˜•์ ์ธ ๊ฒƒ๋งŒ ์žˆ๋‹ค~!)

MG ๋ฐœ์ƒ ๊ธฐ์ „

โœ”๏ธ ์ „์‹ ์  MG : ๋ง‰ ์šด๋™ํ•˜๋‹ค๊ฐ€ ๊ฐ‘์ž๊ธฐ ํ”ฝ ์“ฐ๋Ÿฌ์ง€๋Š” ์• ๋“ค, edrophonium ์ฃผ๋ฉด 20์ดˆ ๋งŒ์— ๋ฒŒ๋–ก ์ผ์–ด๋‚จ.
โœ”๏ธ Focal MG : ์‹๋„/์œ„/์†Œ์žฅ/๋Œ€์žฅ์—๋งŒ ๊ตญ์†Œ์ ์œผ๋กœ ์˜ค๋Š” ๊ฒฝ์šฐ, ์†Œํ™”๊ธฐ ์šด๋™์„ฑ์ด ๋–จ์–ด์ง. โ†’ ์ฆ์ƒ์€ ์†Œํ™”๊ธฐ์ง€๋งŒ ์›์ธ์€ ์‹ ๊ฒฝํ•™์ . ์ˆ˜์ˆ ์ด ์•„๋‹ˆ๋ผ ์•ฝ๋ฌผ๋กœ ์น˜๋ฃŒํ•ด์•ผ ํ•จ.

์‹ ๊ฒฝ ์ „๋‹ฌ ๊ณผ์ •
choline acetyl transferase์— ์˜ํ•ด acetyl CoA๊ฐ€ acetylcholine์œผ๋กœ ๋ฐ”๋€œ, ์ด ๊ณผ์ •์— ์ž‘์šฉํ•˜๋Š” ๋ฏธ๋„ค๋ž„์ด Ca2+.

์ฆ‰, Ca์ด ์žˆ์–ด์•ผ๋งŒ acetylcholine์ด ๋ณด์ž๊ธฐ์ฒ˜๋Ÿผ ๋‹ด๊ฒจ, post-synapse๋กœ ์ด๋™ํ•  ์ˆ˜ ์žˆ์Œ.
  • Hypocalcemia : Ach์ด release๋˜์ง€ ๋ชปํ•ด ๊ทผ์œก ์ด์™„ (์žฅ ์šด๋™ ์ €ํ•˜ ๋“ฑ)
  • Hypercalcemia : ๊ฐ•์ง์ฆ, ์‹ฌ์žฅ ์ˆ˜์ถ•๋ ฅ ์ฆ๊ฐ€(๋นˆ๋งฅ)
    โ†’ Calcium channel blocker - Ach ์ ๊ฒŒ ๋ถ„๋น„, ํƒˆ๋ถ„๊ทน ์ง€์—ฐ, ์‹ฌ์žฅ์„ ์ฒœ์ฒœํžˆ ๋›ฐ๊ฒŒ ํ•จ / ์ด์™„๊ธฐ ๋ฌธ์ œ์ธ HCM ๋“ฑ์— ์ ์šฉ (amlodipine, verapamil, diltiazem)

Medication

  • GI tract funcion ๊ฐœ์„  ์น˜๋ฃŒ
  • Anticholinesterase therapy
  • ํ›„์ฒœ์„ฑ(์ž๊ฐ€๋ฉด์—ญ์„ฑ) โ†’ Immune suppressive therapy : thymoma์— ์˜ํ•ด ํ•ญ์ฒด๊ฐ€ ํ˜•์„ฑ, ํ•ญ์ฒด๋ฅผ ์ฐจ๋‹จํ•˜๋Š” ๋ฉด์—ญ์–ต์ œ์ œ ํ•„์š” (cyclosporine, MMF, leflunomide)
Link to original